Skip to main content

Advertisement

Table 1 Drug use evaluation of cefepime in 96 and 111 patients during cycle A and cycle B, respectively

From: Drug use evaluation of cefepime in the first affiliated hospital of Bengbu medical college: a retrospective and prospective analysis

Items Number of patients (of 96) consistent with the standards in cycle A Number of patients (of 111) consistent with the standards in cycle B
Indication 81 (84.38%) 105 (94.59%)
Drug monitoring   
 Life index record 96 (100%) 111 (100%)
 Blood examination 85 (88.54%) 108 (97.30%)
 Liver function monitoring 75 (78.12%) 101 (90.99%)
 Renal function monitoring 72 (75.00%) 107 (96.40%)
 Bacterial culture and sensitivity test 60 (65.22%)* 98 (88.29%)
 Drug skin test 96 (100%) 111 (100%)
Dosage   
 Dose and duration 70 (72.92%) 100 (90.09%)
 Dosing frequency 70 (72.92%) 100 (90.09%)
 Solvent selection 96 (100.00%) 110 (99.10%)
 Route of administration 96(100.00%) 111 (100.00%)
 Compatibility 95 (98.96%) 111 (100.00%)
Replacement drugs 84 (87.50%) 104 (93.69%)
Combined medication (drug-drug interaction) 58 (62.37%)* 89 (80.18%)
Adverse drug reactions 8 (8.33%) 7 (6.31%)
Outcome 83 (91.21%) 102 (95.33%)
  1. *Some cases could not be evaluated, and the percentage was calculated from the cases that could be evaluated.